SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Tuesday reported a loss of $9.5 million in its second quarter.
On a per-share basis, the South Plainfield, New Jersey-based company said it had a loss of 21 cents. Losses, adjusted for amortization costs, were 9 cents per share.
The biopharmaceutical company posted revenue of $68.7 million in the period.
PTC Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $38.29, a rise of 92 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT